Ra Medical Systems, Inc. (RMED)
Ra Medical Systems, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Carlsbad, CA, US. The stock last traded at $0.59, up 10.00% on the session, giving a market capitalisation of $3.8M. On trailing twelve-month figures it carries a trailing P/E of -0.04, a net margin of -1881.3%. Its beta of 0.00 implies it has historically moved less than the broad market.
Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity vascular disease, through laser radiation ablation. The company primarily channels its products to the U.S. market through a network of distributors. Founded in 2002, Ra Medical Systems' corporate base is located in Carlsbad, California.
Ra Medical Systems, Inc. is most often compared with the following Healthcare names: